Genitourinary cancers require individualized treatment plans based on type, stage, and patient health, utilizing imaging, ...

Chandler H. Park, MD, a medical oncologist at Norton Cancer Institute and advisory dean/professor at University of Louisville in Kentucky, discusses the Category 1 treatment options for metastatic ...

ImmunityBio offers significant upside despite ongoing dilution and cash burn concerns. Click here to read an analysis of IBRX ...

In July 2025, the FDA granted priority review for TAR-200 as therapy for patients with high-risk nonmuscle invasive bladder ...

Immunocompromised status may negatively affect survival outcomes in patients with bladder cancer, a study suggests.

Ohio State researchers have discovered that exhausted T cells collapse under the weight of misfolded proteins, activating a ...

Several medical conditions can mimic prostate cancer, causing many of the same symptoms, including painful ejaculation and blood in the urine. Some of these conditions can also cause elevated prostate ...

(Nasdaq: URGN), a biotech company focused on developing and commercializing innovative solutions for urothelial and specialty cancers, today announced the publication of a comprehensive review of the ...

Researchers hope imaging-based mass spectrometry can be a clinical diagnostic tool for cancer.

In July, University of Colorado football coach and NFL legend Deion Sanders shocked the sports world revealing he had his ...

Post-surgery radiation slashes the risk of locoregional recurrence in patients with advanced muscle-invasive bladder cancer — but what is its role alongside immunotherapy?

In September 2025, the U.S. Food and Drug Administration (FDA) approved several new cancer therapies and supportive care ...